Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11876590 | 0.87 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL8613048 | 0.85 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL8617817 | 0.85 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL9879834 | 0.78 | ALDH1A1 (0.34) | ALDH1A1TSHRHTT | |
| SCHEMBL1245995 | 0.76 | ALDH1A1 (0.33) | ALDH1A1TSHRHTT | |
| SCHEMBL2732854 | 0.74 | TSHR (0.45) | ALDH1A1TSHRHTT | |
| SCHEMBL1114546 | 0.74 | — | — | |
| SCHEMBL7371095 | 0.74 | — | — | |
| SCHEMBL8613379 | 0.74 | ALDH1A1 (0.32) | ALDH1A1TSHRHTT | |
| SCHEMBL175495 | 0.72 | HTT (0.45) | ALDH1A1TSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570677-B2 | Fluorine-containing ether compound, surface treatment agent, fluorine-containing ether composition, coating liquid, article, and production method thereof | AGC Inc. (JP) | 2026-03-10 | — | — | US | disclosed |
| US-12466786-B2 | Separation method | AGC Inc. (JP) | 2025-11-11 | — | — | US | disclosed |
| US-12264257-B2 | Composition containing a fluorinated ether compound | AGC Inc. (JP) | 2025-04-01 | — | — | US | disclosed |
| US-11773216-B2 | Fluorine-containing ether compound, composition and article | AGC Inc. (JP) | 2023-10-03 | — | — | US | disclosed |
| US-20230250052-A1 | SEPARATION METHOD | AGC Inc. (JP) | 2023-08-10 | — | — | US | disclosed |
| US-20220298180-A1 | FLUORINE-CONTAINING ETHER COMPOUND, SURFACE TREATMENT AGENT, FLUORINE-CONTAINING ETHER COMPOSITION, COATING LIQUID, ARTICLE, AND PRODUCTION METHOD THEREOF | AGC Inc. (JP) | 2022-09-22 | — | — | US | disclosed |
| WO-2022059683-A1 | SEPARATION METHOD | ＡＧＣ株式会社 | 2022-03-24 | — | — | WO | disclosed |
| WO-2022039172-A1 | FLUORINE-CONTAINING ETHER COMPOUND, FLUORINE-CONTAINING ETHER COMPOSITION, COATING LIQUID, ARTICLE, AND METHOD FOR PRODUCING ARTICLE | ＡＧＣ株式会社 | 2022-02-24 | — | — | WO | disclosed |
| US-5827855-A | ANTICHOLESTEROL AGENTS TREATING CARDIOVASCULAR DISORDERS; ENZYME INHIBITORS | SANKYO COMPANY, LIMITED (JP) | 1998-10-27 | — | — | US | disclosed |
| US-5451688-A | Inhibit biosynthesis of cholesterol | SANKYO COMPANY, LIMITED (JP) | 1995-09-19 | — | — | US | disclosed |
| EP-0605230-A1 | Hexanhydronaphthalene ester derivatives, their preparation and their therapeutic uses | SANKYO COMPANY LIMITED (JP) | 1994-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12466786-B2 | Separation method | HAO2, FOXM1, PFN1 | ALDH1A1 1081/4885TSHR 1696/4885HTT 1095/4885 |
| US-20220298180-A1 | FLUORINE-CONTAINING ETHER COMPOUND, SURFACE TREATMENT AGENT, FLUORINE-CONTAINING ETHER COMPOSITION, COATING LIQUID, ARTICLE, AND PRODUCTION METHOD THEREOF | FLNB, EPCAM, FLNA | ALDH1A1 2690/4885TSHR 2181/4885HTT 4687/4885 |
| US-11773216-B2 | Fluorine-containing ether compound, composition and article | FBL, NR1H3, NAF1 | ALDH1A1 2983/4885TSHR 2392/4885HTT 3911/4885 |
| US-20230250052-A1 | SEPARATION METHOD | PFDN6, PCLAF, PFDN2 | ALDH1A1 1446/4885TSHR 3615/4885HTT 786/4885 |
| US-12570677-B2 | Fluorine-containing ether compound, surface treatment agent, fluorine-containing ether composition, coating liquid, article, and production method thereof | RIF1, SGMS1, FRG1 | ALDH1A1 601/4885TSHR 1448/4885HTT 4792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.